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Abstract
Background: Oxytocin (OXT) acts through its specific receptor (OXTR) and increased density of OXTR and/or
augmented sensitivity to OXT were postulated as prerequisites of normal onset of labor. Expression of OXTR in the
placental term trophoblast cells has not yet been analyzed in the context of contractile activity of the uterus. Here
we examine comparatively OXT contents in the placental tissue adjacent to the uterine wall and expressions of
OXTR in this tissue and corresponding isolated placental trophoblast cells.
Methods: Twenty eight placentae after normal labors at term (group I, N = 14) and after cesarean sections performed
without uterine contractile activity (group II, N = 14) have been collected. Tissue excised from the maternal surface of
examined placenta was used for OXT concentration measurement, cytotrophoblast cell cultures preparation and
immunohistochemistry of OXTR. Concentration of OXT was estimated in the tissue homogenates by an enzyme
immunoassay with colorimetric detection. Cytotrophoblast cells were isolated using Kliman’s method based on
trypsin, DNase, and a 5–70 % Percoll gradient centrifugation. The cultures were incubated for 5 days in normoxia.
Both placental specimens and terminated cytotrophoblast cultures were fixed and embedded in paraffin before
being immunostained for OXTR. Using light microscopy with computed morphometry for quantitative analysis,
OXTR expressions were estimated in calibrated areas of the paraffin sections.
Results: There were not significant differences between the groups in respect to the mean OXT concentration.
However, in both groups the median value of OXT concentration was significantly (p < 0.05) higher in the tissue
obtained from the peripheral regions of the maternal surface of the placenta, compared to the samples from the
central region of this surface. In placental tissue the mean expression of OXTR in group I was significantly (p < 0.05)
increased by approximately 3.2-fold and 3.45-fold (the samples collected from central and peripheral regions, respectively)
compared to the values obtained in group II.
In the isolated primary trophoblast cultures the differences were even more evident (p < 0.02) and the mean change in
OXTR expression in group I comprised approximately 6.9-fold increase and 6.5-fold increase (the samples collected from
central and peripheral regions, respectively) compared to the values obtained in group II.
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Conclusions: Upregulation of OXTR within placental trophoblast cells localized close or adherent to uterine wall may
play a crucial role in labor with efficient contractile activity (vaginal delivery). Further studies may disclose if this local
OXT/OXTR signaling is utilized in the third stage of labor to elicit placental detachment or contribute in a more versatile
way throughout the labor period.
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Background
Normal onset of labor with maintained regular intrauter-
ine contractions leading to shortening and cervical dila-
tion (first stage), expulsion of the fetus (second stage) and
placental delivery followed by uterine contraction and re-
traction (third stage) are needed for successful pregnancy
outcome [1]. Some mechanism that trigger the contractile
activity of the myometrium are still not clearly under-
stood, including those responsible for detachment of the
placenta [2]. Local interactions between the two adjacent
surfaces: placental (the maternal side) and the correspond-
ing decidual/myometrial surface area would be considered
extremely significant in terms of ability to maintain preg-
nancy to term and the proper course of parturition [3].
Interestingly, the role of oxytocin (OXT) seems to be
more complex than it was suggested before. This nona-
peptide (or more precisely the octapeptide amide with
amino acid sequence: Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-
Gly-NH2) was discovered initially as a neuropeptide [4, 5].
In the hypothalamus, OXT is synthesized as an inactive
precursor protein that is progressively activated by gradual
hydrolysis into smaller fragments while it is being relo-
cated along the axon towards the posterior pituitary. The
last step of this activation is catalyzed by peptidylglycine
alpha-amidating monooxygenase (PAM, EC 1.14.17.3) [6].
Finally, OXT is released to the blood stream and acts
directly via axon terminals on OXT receptors (OXTR) in
the CNS (e.g. the nucleus accumbens) [7]. Amongst other
peptides that act locally (e.g. corticotropin-releasing hor-
mone, and dynorphin), OXT and vasopressin are the only
known hormones secreted by the human neurohypophysis
to act at a distance [8].
The structure of OXT is higly conserved in placental
mammals. However, in some new world primates, a novel
structures of OXT have been reported [9]. OXT, and an-
other very similar (differs by only two amino acids) nona-
peptide – vasopresin, were isolated and synthetized in
1953 by Vincent du Vigneaud [10, 11]. OXT has a disul-
fide bond between the two cysteines, and reduction of the
disulfide bond inactivates OXT [5].
An intricate interplay between OXT and OXTR is re-
sponsible for various functions of OXT acting as neuror-
egulator or in a paracrine manner in ovary or uterus,
including materno-placento-fetal unit [1, 6]. Despite of
the fact that OXT evokes uterine contractions, some
discrepancies about the exact role of OXT in partur-
ition have arisen in the mid 1980s, after the first sug-
gestion that OXT synthesis also occurs in peripheral
tissues [12, 13]. Outside the brain, synthesis of mRNA
encoding OXT was demonstrated in many human tis-
sues, including intrauterine tissues in advanced gesta-
tion, principally in the decidua but also in the placental
membranes (chorion, amnion) [14, 15]. These findings
may lead to suggestion that paracrine or autocrine role
rather than, or in addition to, an endocrine role of OXT
should be expected in respect of contractile activity of the
human uterus [16, 17]. So if OXT is not considered solely
as an endorine factor, many previous conclusions about its
effect on the course of subsequent stages of pregnancy
and labor should be retested [6].
In contrast to vasopresin, OXT is known to have only
one type of specific, high-affinity receptor (OXTR). The
human OXTR mRNAs were found to be of two sizes,
3.6 kb in breast and 4.4 kb in ovary, endometrium, and
myometrium. The OXTR gene is present in single copy
in the human genome and was mapped to the gene
locus 3p25–3p26.2 [18, 19] OXTR belongs to the
rhodopsin-type (class I) G protein (Gαq11)-coupled re-
ceptor family that requires Mg2+ and cholesterol [20].
OXTR is coupled to phospholipase C (PLC, EC 3.1.4.11)
which controls the generation of diacylglycerol (DAG)
and inositol 1,4,5 – trisphosphate (InsP3). Thus, after
activation of OXTR, inositol triphosphate triggers an in-
crease in Ca2+ influx from both extracellular and intra-
cellular stores, whereas DAG stimulates activation of
protein kinases type C (PKC, EC 2.7.11.13), which phos-
phorylates unidentified target proteins. The OXTR has a
weak ligand selectivity profile. It was proved that OXTR
is able to couple to different G proteins, including Gi
and Gs proteins [21].
Expression of OXTR in the pregnant and non-pregnant
myometrium differs significantly [22, 23]. Activation of
functional OXTRs stimulates cell proliferation in human
placental trophoblast and choriocarcinoma cell lines [24].
Increased density of OXTR and/or augmented sensitivity
to OXT were postulated as prerequisites of effective par-
turition with normal induction of uterine contractions
[22, 25]. These changes observed at transcription and
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protein levels during pregnancy resulting in heterogenous
OXTR expression in the term myometrium [22].
However, there are still serious controversies about exact
role of OXTR in the initiation of uterine contractions in
term pregnancy. It is not known precisely how the increase
in OXTR mRNA concentrations in the myometrium and
decidua is regulated and what is the contribution of
OXTR within the placental tissue. Both, existence of
a desensitization mechanism for post-transcriptional
regulation of the OXTR, and interplay between OXT
and prostaglandins (PGF2α, PGE) may be rather responsible
for the crucial stage of the liberation of uterine contractions
at term [26, 27]. Quite recently the new approach has
arisen suggesting that OXTand OXTR interactions are cru-
cial to preserve myocyte regeneration and proliferation ra-
ther than induction of the uterine contractile activity [28].
Expression of OXTR in the placental term trophoblast
cells of the maternal side, contiguous to the uterine wall
has not yet been analyzed thoroughly in humans in the
context of contractile activity of the uterus. Development
of a suitable model for investigation of OXTR expression
in the cytotrophoblast enabling a novel approach to this
issue may yield interesting contribution to our understand-
ing of the third stage of labor, above all else may shed some
light on the mechanism of placental detachment. The in-
teractions between placental prostaglandins and OXT, for
example, have been discussed comprehensively, however,
not in relation to trophoblast pool of OXTR [29].
The aim of this study was to examine comparatively
OXT contents in the placental tissue adjacent to the
uterine wall and expressions of OXTR in this tissue
and corresponding isolated placental trophoblast cells
obtained after normal labors at term and after cesarean
sections performed without spontaneously induced
uterine contractions (group I and II, respectively).
Methods
The study was conducted in compliance with international
and local laws of human experimentation and was offi-
cially approved by local ethics committee of the Medical
University of Warsaw (ethical clearance approval number:
KB21/2011). Each woman has signed a written consent for
the use of her placentae as the source of trophoblast cells.
Strictly speaking, this work has been carried out in accord-
ance with The Code of Ethics of the World Medical Asso-
ciation (Declaration of Helsinki) for experiments involving
humans, and the Uniform Requirements for manuscripts
submitted to Biomedical Journals have been fulfilled.
Placental tissue collection
Fourteen placentae obtained from nulliparas after nat-
ural unifetal vaginal births (group I) were compared with
equal number of gestationally matched placentae collected
after elective cesarean sections (group II). The indications
for cesarean section were high-grade myopia in pregnant
woman and breech presentation of the fetus. More
detailed clinical characteristics of the two homogenous
(except for the mode of delivery) groups are given in
Table 1. As previously mentioned, uterine contractile ac-
tivity was not observed in group II.
From each collected placenta, three specimens were
excised in a standardized manner from the region con-
tiguous to the maternal surface of the placenta: the first
one – from the central part, the next two – from periph-
eral regions of the placental maternal surface (Fig. 1). All
placentae used in this study were complete and charac-
terized by a central umbilical cord insertion. In all cases
enrolled in group I, expulsion of the placenta was pre-
ceded by its normal separation (so-called shiny Schultz)
[30]. The management of the third stage of labor was ac-
tive with umbilical cord clamped immediately after delivery
of the newborn and oxytocin (5 IU) administered i.v. to the
mother. Similarly, oxytocin (5 IU) was administered during
cesarean section following delivery of the newborn. The
tissue material obtained by this procedure was subjected
either to freezing in carbon dioxide snow for OXT con-
centration measurement or served as a source of cyto-
trophoblast cells for the development of in vitro cultures.
Appropriate specimens were also embedded in paraffin
and used for for immunohistochemistry of OXTR.
Measurement of OXT content
Concentration of OXT was estimated in the frozen placen-
tal excisions. During this procedure, the tissue was kept on
ice. Before obtaining a lysate, the material was initially cut
into about 1 mm3 cubes by using a razor blade on a glass
plate held on ice. To perform a gentle cell disruption, the
cubes were then transferred into a hand-held Potter S
homogenizer from Sartorius™ Stedim Biotech GmbH. The
liquefied tissue was poured into the 1.5 mL tubes and cen-
trifuged at 10,000 xg for 3 min at 4 °C. The clear super-
natant was subjected to in vitro quantitative measurement
of OXT in the placental tissue homogenates by an enzyme
immunoassay with colorimetric detection. The Oxytocin
ELISA-Kit – (Cat. no. ADI-901-153A-0001) – Enzo Life
Sciences, Inc. (USA) was applied with declared by manu-
facturer sensitivity level at 15 pg/ml (detection range:
15.6–1.000 pg/ml). This species independent kit uses
a polyclonal antibody to OXT to bind, in a competi-
tive manner, the OXT in the standard or sample or
an alkaline phosphatase molecule which has OXT co-
valently attached to it. Following simultaneous incu-
bation at 4 °C, the excess reagents are washed away
and subtrate is added. After a short incubation time the
enzyme reaction is stopped and the yellow color generated
read on a microplate reader (Biochrom Asys UVM-340
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Fig. 1 Location of samples (I – III) collected from the maternal surface of the placenta. The mean weight of the sample: 49.76 ± 4.54 g
Table 1 Clinical characteristics of the two groups studied (median and range). The groups may be treated as homogenous, except





Number of patients/newborns/placentas/specimens obtained (N) 14/14/14/42 14/14/14/42
Parity 0 0
Gestational age in days (median; range) 283; 269–290 276; 265–282
Preterm uterine contractions Not reported Not reported
Contractile activity of the uterus at time of delivery Present and effective Not present
Oxytocin treatment in the first and second stage of labour Not used Not used
Blood pressure during pregnancy All records within normal rangea All records within normal rangea
Proteinuria during pregnancy Not present Not present
Liver blood tests (aminotransferases enzymes, AST and ALT levels) Within normal rangeb Within normal rangeb
Diabetes during pregnancy Not present Not present
Body mass index <21 or >35 None None
Mother’s blood (III trimester): hematocrit (Ht),
hemoglobin (Hb), red blood cell (RBC) count,
mean cell hemoglobin concentration (MCHC)
All within normal rangesc All within normal rangesc
Other identified risk factors None None
Birth weight in grams (median; range) 3380; 2990–3730 3190; 2850–3860
5-minute Apgar score below 8 pointsd None None
Sex of newborns (M, male; F, female) 7 M + 7 F 8 M + 6 F
Weight of placenta in grams (median; range) 660; 559–790 650; 550–810
aThe normal range of blood pressure was defined as systolic pressure between 100 and 140 mmHg, and diastolic pressure between 60 and 90 mmHg
bThe normal range of values for AST is 5–40 units per liter of serum and the normal range of values for ALT is 7–56 units per liter of serum
cHb levels 10.0–13.5 g/dl, RBC count 3.2–4.4 million/μl, MCHC 319–355 g/L, Ht 31–41 %
dApgar score is determined by evaluation newborn on five criteria that form a backronym (Appearance, Pulse, Grimace, Activity, Respiration) on scale from “0“ to
“2“. The scores are added up and the total sum is an Apgar score. Scores 7 and above are generally nomal, 4–6 fairly low, and 3 and below generally regarded as
critically low
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Microplate Reader by Biochrom Ltd., Cambridge, UK) at
405 nm. The intensity of the bound yellow color was in-
versely proportional to the concentration of OXT in
either standards or samples. Thus, the measured op-
tical density was used to calculate the concentration of
OXT. Relatively low (not exceeding 7–7.5 %) cross re-
activity with Arg8-vasotocin (vasopressin) and very low
reactivity for other related molecules (<0.02 %) provided
confidence in OXTassay results. Finally, the concentration
of OXT measured by ELISA were converted into ng/g of
wet placental tissue. The intra-assay precision (% CV)
amounted to 11.4 and the inter-assay variance (% CV)
was 16.1.
Trophoblast in vitro cultures
Concurrently with the measurement of OXT content,
preparation of the cell cultures has begun. Cytotropho-
blast cells were isolated using modified Kliman’s method
as described elsewhere [31–33]. This method is based on
trypsin, DNase, and a 5–70 % Percoll gradient centrifu-
gation. Briefly, immediately after obtaining each speci-
men of the placental tissue was denuded from decidua
fragments and abundantly rinsed with 0.9 % saline to re-
move all blood. A minced villous tissue was subjected to
30 min enzymatic digestion at 37 °C during incubation
in shaking water bath in CMF-HBSS (calcium- and
magnesium-free Hank’s balanced salt solution; 10 × stock
solution from Life Technologies Inc. Gibco/Brl, NY, USA)
with 0.125 % trypsin (Sigma-Aldrich Inc., USA; T8003)
and 0.2 mg/ml deoxyribonuclease I (DNase I Type IV;
Sigma; D5025). Such digestion was performed sequentially
four times. Each time a freshly prepared digestive mixture
(solution) was used to the next placental samples. The
cells that were released at every 30 min step were pooled
and filtered through two layers of gauze, and trypsin was
inactivated with fetal calf serum (FCS). The filtrates were
centrifuged, and the cell pellets were resuspended in PBS.
The resultant cell suspension in supernatant was
filtered and fractionated on a 5–70 % Percoll (Sigma;
P1644) gradient centrifugation (1200 × g for 25 min).
The cell layers incorporated into a range 40-50 %
(density 1.048–1.062 g/ml) have been collected,
washed and resuspended (1 × 106 cells/ml) in Ham’s
F12/Dulbeco’s modified Eagle’s medium (1:1; Sigma;
51445C) with 15 % fetal bovine serum (Gibco/Brl;
26140–079), 1 mmol/l sodium pyruvate, 2 mmol/l L-
glutamine, and 50 μg/ml gentamycin. The cultures
were then incubated for 5 days under normoxic
(20 % O2) conditions at 37 °C with 5 % of CO2, with
the media changed daily. The purity of the cytotro-
phoblast culture developed from each placenta was
evaluated by immunoperoxidase staining with anti-
bodies against vimentin. Described procedure yielded
preparation of a highly purified cytotrophoblast
(approx. 95 % pure) with the mean viability ≥ 90 %.
Immunohistochemistry of OXTR
Placental tissue samples
Human placenta paraffin 5 μm sections were subjected
to the immunohistochemical staining. Goat anti-human
polyclonal IgG (N-terminal) antibody to OXTR (Abnova
Corp. Taipei, Taiwan; ABIN1049194; concentration 9 μg/ml)
was applied as primary and chicken anti-goat IgG (heavy
and light chains) as biotinylated secondary antibody
(Abnova; PAB10566; 0.5 % v/v). In order to highlight
the specifically bound primary antibodies to OXTR,
the StreptAB-Complex/HRP Duet (Dako Cytomation,
Glostrup, Denmark; K0492) was used, following the
protocol recommended by the manufacturer, with 3,3’–
diaminobenzidine that served as a chromogen. The appro-
priate negative controls for all immunostainings were
established simultaneously by replacement of the poly-
clonal primary antibody by normal goat preimmune IgG
diluted with phosphate buffered saline (PBS), containing
3 % bovine serum albumin at the same protein concentra-
tion as that used for the primary antibody.
In view of the fact that OXTR are expressed in vascu-
lar endothelial cells, it was presumed that the accuracy
of OXTR expression measurement may be significantly
influenced by the local differences in density of placental
microvessels. To avoid this discrepancy in the results,
identification of the vasculature elements in placental
sections was performed using endothelial cell maker,
rabbit polyclonal antibody anti-CD31 (dilution 1 : 50,
Abcam Inc., Cambridge, MA, USA; ab28364). Next, a bio-
tinylated goat anti-rabbit antibody was used as the sec-
ondary (Abcam).
Using light microscopy with computed morphometry
for quantitative analysis (Quantimet 500C+ image analysis
workstation provided by Leica, UK), the vascular/extravas-
cular tissular index (V/EVTI) was estimated in calibrated
areas of the placental sections, as described in detail else-
where [34–36]. Briefly, each specimen (paraffin section)
underwent three area analyses repeated by two experi-
enced, independent observers. The single area measured
with the picture analyzer amounted to 685254 μm2 and
the total number of specimens 42 per group. The picture
analysis procedure consisted in a measurement of the total
vascular area. Consequently, the total lumen area of all
types of identified vessels was summed up in both groups.
With the purpose of a minimizing disruption caused by
technical errors, especially unaxial section of the vessel,
the lowest value of Ferret’s diameter was accepted as the
diameter of single lumen. Thus, V/EVTI represents the ra-
tio, which reflects intensity of vascularization and is most
closely correlated with the mean density of placental
microvessels.
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Cytotrophoblast
After 5 days the cultures were terminated, formalin-fixed
and paraffin-embedded. The paraffin blocks containing
cytotrophoblast cells were cut in 4 μm-thick sections on a
microtome with a disposable blade. Visualization of OXTR
was performed using standard immunohistochemical
pocedures as already described above (see Chapter 2.4.1.)
with exception for V/EVTI.
Expression of OXTR
In order to assess OXTR expression, a quantitative immu-
nohistochemistry based on morphometric software
(Quantimet 500C+) was performed twice by two inde-
pendent researchers. Next, the average values were
uploaded into the result recording tab. Intensity of
immunostaining was evaluated using mean color satur-
ation parameter and thresholdings in grey-level histo-
grams. Thus, expression of OXTR corresponded to the
total immunostained area of examined sections, where
the color saturation comprises segmentation/separation
criteria for objects. A single analysed image area was
131574 μm2 (magnification ×200). In total, 126 visual
fields have been analysed (9 visual fields per placenta)
in each studied group.
During comparative measurements of OXTR expression
in placental tissue samples in both groups, the vascular
density-matched samples were analyzed. In any case,
the difference between the mean V/EVTI values not
exceeded ± 5 % [37]. Morphometric results comprising
90 % confidence intervals were reported as the mean
fold changes. Naturally, expression of OXTR in the isolated
cells of placental cytotrophoblast was estimated without
taking into consideration the vascular density.
Application of highly specific antibodies for immuno-
staining of OXTR together with quantitative imunohis-
tochemistry made it possible to disclose the nature of
interrelationships between contractile activity of the
uterus and placental expression of OXTR, including iso-
lated trophoblast cells (Fig. 2).
Statistical analysis
All statistical analyses were performed using Statistica
8.0 software (Stat-Soft, Poland). Mann-Whitney’s U test
was applied. The results are expressed as the mean ±
SEM, medians or mean percentage values ± SEM. The
differences between groups I and II (natural vaginal birth
vs. cesarean section without contractile activity of the
uterus) were deemed statistically significant if p < 0.05.
Results
To compare OXT levels in the placenta from vaginal ans
CS births, placental extracts were analyzed by a standard
Fig. 2 Immunohistochemical visualization of OXTR. a, b – placental samples (the image captured through optical microscope was subjected to series of
digital transformations for morphometric purposes; initial magnification 400×); c – trophoblast cells in culture (phase –contrast image); d – trophoblast
culture immunostained for OXTR (the image digitally transformed for morphometric purposes). The OXTR is represented by the category of blue hues
ranged from dark blue to violet blue. Scale bar = 100 μm. CT – cytotrophoblast, ST – syncytiotrophoblast, fv – fetal vein, fa – fetal artery
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ELISA assay. The results pertaining to OXT content in
the placental tissue homogenates are summarized in Fig. 3.
There were not significant differences between the groups
in respect to the mean OXTconcentration in the placental
samples obtained from the maternal surface of the pla-
centa. The mean value for the total number of samples in
group I amounted to 56.82 ± 4.78 ng/g of wet tissue ±
SEM, while in group II the mean OXT content was esti-
mated to be 54.35 ± 4.93 ng/g of wet tissue ± SEM.
It is worth noting that the mean OXT concentration
revealed correlation with the location of samples. How-
ever, considering that the data are not normally distrib-
uted within the groups, the median values (the middle
values) have been juxtaposed.
As this may be quite important, in both groups the me-
dian value of OXTconcentration was significantly (p < 0.05)
higher in the tissue obtained from the peripheral re-
gions of the maternal surface (Fig. 3b), compared to the
samples from the central region (Fig. 3a). In group I
(vaginal delivery) the respective median values
amounted to 59.97 ng/g of wet tissue and 47.39, re-
spectively, while in group II (elective cesarean section)
the median values of OXT concentration were esti-
mated to be 59.91, and 43.45 (peripheral and central
region, respectively).
Relative changes in the mean OXTR expression in the
placental samples and in the trophoblast cultures are
shown in Fig. 4 (4a and 4b, respectively). It is clearly vis-
ible that in placental samples obtained after vaginal de-
livery (group I) the mean density of OXTR undergoes
significant (p < 0.05) upregulation. The mean expression
of OXTR in group I was increased by approximately 3.2-
fold and 3.45-fold (the samples collected from central
and peripheral regions, respectively) compared to the
values obtained in group II (cesarean section).
The results of comparative evaluation of the mean
OXTR expression in the isolated primary trophoblast
cultures (Fig. 4b), which means that the influence of
the placental vasculature was eliminated, revealed gen-
erally the same characteristics of dependencies as already
observed for placental samples. However, the differences
were even more evident (p < 0.02). The mean change in
OXTR expression in group I (vaginal delivery) comprised
approximately 6.9-fold increase and 6.5-fold increase (the
samples collected from central and peripheral regions, re-
spectively) compared to the values obtained in group II
(cesarean section).
Discussion
The control of timing of labor is achieved by complex
interactions between mother, fetus and the placenta.
Since the contact area of the maternal side of the human
placenta is relatively large, this organ may influence uterine
contractility throughout a pregnancy. Both local (limited to
the site of placental attachment) and all-encompassing in-
terrelationships should be better elucidated [38]. Our re-
sults indicate that despite of similar OXT concentration in
the placental tissue, the OXTR density may determine on-
set of the myometrial contractions at the time of delivery.
Independent authors already reported that the progress of
labor is not related to an increase in OXT concentration,
uterine contractions are not associated with changes in
plasma OXT concentration and hypocontractile labor does
not appear to be the result of a deficit of OXT [39]. These
authors concluded that their results do not support a role
of OXT during spontaneous labor unless uterine activity is
Fig. 3 Oxytocin (OXT) concentration in placental tissue obtained from central a and peripheral b regions of the maternal surface. The median
values for the groups were marked
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controlled by extremely low plasma hormone concentra-
tions or the uterus becomes sensitive to a constant OXT
concentrations [39]. Considering our findings, the latter
condition may be caused by region-specific upregula-
tion of OXTR.
The mechanisms utilized to initiate and coordinate
contractile activity of the uterus during labor are not known
[1, 40]. Existence of an pacemaker, a site where the action
potential (AP) is generated, forms the basis of the canonical
AP propagation theory [41]. In all excitable tissues, includ-
ing uterine smooth muscle cells, AP resulting from the
depolarization of the cell membrane (sarcolemma) is the
trigger for many intracellular events. First of all, depolarized
plasma membrane opens voltage-sensitive ion channels
resulting in highly increased entry of extracellular Ca2+
which in turn causes calcium-dependent uterine con-
tractions, especially in calcium-sensitized myometrium
[42]. Two types of APs have been observed in myometrial
smooth muscle cells: simple AP with depolarization
followed by rapid repolarization, and complex AP, where
initial depolarization devolves into sustained plateau. It
has been suggested, that these different patterns of elec-
trical activity may result from other combinations of ionic
currents during the course of given type AP [43, 44].
Apart from this, after many years of investigations, the
concept of pacemaker is still an open debate since there
is no evidence for the presence of cells with such histo-
logic or electrophysiologic characteristics. It was even
suggested that all uterine smooth muscle cells have the
capacity to act as pacemaker cells, and thereby initiate
the contractions [41]. Some researchers have postulated
the existence of a unique, subendometrial junctional zone
of the myometrium that may generate and regulate these
bioelectrical activities [45]. Thus, changed properties of pla-
cental cells adjacent to the decidua may significantly affect
contractile status of the uterus [46, 47]. As in the uterus,
OXT also stimulates production of prostaglandins, includ-
ing PGF2α in the decidua, amnion and cytotrophoblast [48].
It was suggested that estrogen stimulated, local production
of OXT within the chorio-decidual and trophoblast cells
may contribute to the modulation of AP promoting forma-
tion of the complex APs [49].
Calcium sensitization (CS) is considered as a poten-
tially significant functional mechanism for the regulation
of uterine contractility. In this condition, especially after
stimulation with an agonist such as OXT, a given influx
of Ca2+ will cause a larger than expected strenght of con-
traction [48]. Amongst various uterotonins evaluated for
their ability to evoke CS, the effects of OXT have been ana-
lyzed thoroughly. It has became evident that CS plays im-
portant role in potentialization of the contractile effects of
OXT on the human myometrium [22, 49]. Our results thus
suggest that, depending on OXTR expression, the same
level of CS produced by similar concentrations of OXT
may be sufficient or unable to generate a sustained regular
uterine contractions. It should be considered whether
Fig. 4 Group I vs. group II. Mean fold increase in OXTR expression in placental samples a and the trophoblast cultures b. The data are expressed as
mean ± SEM (* indicates p < 0.05; indicates p < 0.02)
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local functional changes in placental tissue during the
short period immediately preceding onset of labor may
upregulate OXTR [50]. Because OXT in uterine tissue ac-
tivates OXTR and another member of the G protein-
coupled receptor (GPCR) family, vasopressin V1A receptor,
the local expression of this latter may also influence uter-
ine contractility. However, V1A receptor affinity and
potency of OXT are much lower than those of vaso-
pressin [51].
Immunohistochemical stainings of the placental sam-
ples have revealed that OXTR are expressed in both vas-
cular endothelial cells and trophoblast cells (Fig. 3a). In
view of this, assessment of OXTR expression performed
in placental sections in conjunction with the mean dens-
ity of placental microvessels (V/EVTI) as well as the use
of isolated trophoblast cells in culture are justified in our
study. In that way, we were able to demonstrate that
perinatal upregulation of OXTR take place predomin-
antly or is even limited to the trophoblast cells located
on the maternal side of term placenta. To the best of
our knowledge, this is the first publication pertaining to
humans aimed at assessing placental OXT concentration
in the context of uterine contractility and OXTR density
in both placental tissue and isolated trophoblast cells.
Interestingly, in both groups the mean OXT concen-
tration was higher in the peripheral regions of the pla-
centa compared to the central region. It may indicate
that significant differences in the basal level of CS could
be an important factor influencing contractility of the
uterus, possibly during delivery of the placenta. The
most commonly observed birth of the placenta by the
Schultz Mechanism include the formation of a retropla-
cental hematoma between the separating placenta and
remaining spongiosa layer of the decidua. It facilitates
the completion of placental separation [52]. Thus, to-
gether with an optimal expression of OXTR, different
CS of the myometrium within the placental site evoked
by changes in OXT concentration may play a role in the
typical mechanism of placental separation during the
third stage of labor. It can be speculated that in less
common the Matthew Duncan mechanism of placental
detachment, as well as in many disorders of the placen-
tal stage of labor, expression patterns of OXTR may be
different [2, 53].
Contrary to above deduction, observed changes in the
mean OXT concentration between central and peripheral
regions of the maternal surface may be a consequence of
dissimilar number of cells in the placental tissue obtained
from different locations. This possibility was mentioned
by some independent authors [54, 55]. In addition, to
some extent the differences in distribution of placental
microvessels and resulted diverse blood supply may
contribute to the above results. It should also be taken
into account that non-contemporaneous differentiation
of the trophoblast in the primary cultures may influ-
ence the results pertaining to OXTR expression. The
assessment of trophoblast differentiation was not per-
formed in this study.
If we focus on the tissue level, AP propagation theory
is sufficient to explain induction of the uterine contrac-
tions. However, given the difficulty AP propagation alone
has explaining organ-level function, largely forgotten
idea of mechanotransduction by pressure-tension sens-
ing should be re-considered [40, 56]. According to this
concept, based on Laplace’s Law, the contractions may
be controlled by stretch of the uterine wall while signifi-
cant increase of intrauterine pressure causes increases of
wall tension. Next, the optimal level of the wall tension
activates contractions throughout the uterus. It is very
likely, that both AP propagation from uterine pacemaker
and mechanotransduction are complementary and may
be helpful with blanket conceptualization of the uterine
contraction phenomenon [57]. It is possible that the
mechanism of placental detachment from not initially
contracting part of the uterine utilizes the pacemaker as
the main mechanism of AP activation, while mechano-
transduction mechanism is needed for an organ-level
coordination of myometrial repetitive, synchronous
contractions during normal human labor [58]. Based
on our results, we suspect that interaction between
OXT and OXTR is an important part of this functional
machinery that may be explained using both action
potential (AP) and mechanotransduction theories.
In conclusion, the results indicate that upregulation of
OXTR within placental trophoblast cells localized close
or adherent to uterine wall may play a crucial role in the
mechanisms involved in labor with efficient contractile
activity. Further studies are needed to disclose if this
local OXT/OXTR signaling is utilized in the third stage
of labor to elicit placental detachment or contribute in a
more versatile way throughout the labor period, includ-
ing initiation of labor.
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